Pharma Journalist -

The U.S. Food and Drug Administration today expanded the approved use of Stivarga (regorafinib) to include treatment of patients with hepatocellular carcinoma (HCC or liver cancer) who…
Read More...

Savara Inc., a clinical-stage specialty pharmaceutical company focused on the development and commercialization of novel therapies for the treatment of serious or life-threatening rare…
Read More...

Valeant Pharmaceuticals International, Inc.'s wholly owned subsidiary, Bausch + Lomb, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA)…
Read More...

Results from the phase 3 REPROVE study assessing Pfizer's fixed-dose antibacterial combo Zavicefta (ceftazidime-avibactam) in patients with hospital-acquired pneumonia (HAP)…
Read More...

Science 37 has raised $29m in Series C funding, led by Glynn Capital Management with participation from GV, to bring clinical trials directly into patients’ homes. The round included…
Read More...

scPharmaceuticals announced that John Tucker has been appointed as president and CEO and also elected to the board of directors effective immediately. Mr. Tucker holds a BA from…
Read More...

INTREXON Corporation announced the appointment of Lupin's CEO Vinita Gupta to its Board of Directors effective from April 25, 2017. Ms. Gupta has served as CEO of India-based Lupin…
Read More...

Sutro Biopharma Inc named Crestovo CEO and COO Joseph M. Lobacki to its board of directors. Mr. Lobacki previously served as chief commercial officer of Medivation. He also served…
Read More...

Servier and CTI BioPharma Corp.  jointly announced that they will expand their existing license and development collaboration agreement for PIXUVRI (pixantrone). Under the expanded…
Read More...

According to the study published in the journal of the American Academy of Ophthalmology, the researchers used deep-learning methods to create an automated algorithm to detect diabetic…
Read More...